April 9, 2025
Ipsen publishes its 2024 Universal Registration Document
Ipsen publishes its 2024 Universal Registration Document PARIS, FRANCE, 8 April 2025 – Ipsen (Euronext: IPN; ADR: IPSEY)…
Pharmaceuticals, Biotechnology and Life Sciences
Ipsen publishes its 2024 Universal Registration Document PARIS, FRANCE, 8 April 2025 – Ipsen (Euronext: IPN; ADR: IPSEY)…
–EFFICACY: 92% median reduction in disabling seizures during 7-12-month efficacy endpoint period, and 80% (4/5) of patients responding with >75%…
CVN293 was generally well-tolerated in healthy volunteers with evidence of robust brain penetration, supporting utility of KCNK13 inhibitors for neurodegenerative…
Las Vegas, Nevada, April 07, 2025 (GLOBE NEWSWIRE) — Tanke Biosciences Corp (the “Company”) (OTC: TNBI) announced today that John…
Auditor Licensing & Personnel Issues Delays Issuance of Audit OpinionThe Company expects to file within 1 week TORONTO, April 07,…
SARASOTA, Fla., April 07, 2025 (GLOBE NEWSWIRE) — Oragenics, Inc. (NYSE American: OGEN), a biotechnology company focused on developing novel…
Oncodesign Services has appointed Dr. Aidan Synnott as chief executive officer, to help strengthen its position as a trusted partner in drug discovery. The appointment reflects the company’s commitment to deepen client collaboration, enhance the quality of its science, and anticipate the evolving needs of the biopharma industry.
Evestia Clinical is kicking off with new identity of EMAS Pharma, as it sets its sights on rapid growth as a…
A UK biotech company Aelius Biotech whose unique laboratory gut model is used to trial new drugs and foodstuffs without the need for animal testing has raised a further £750,000 from the North East Venture Fund, supported by the European Regional Development Fund and managed by Mercia Ventures.
High Force Research, a leading provider of specialist chemical R&D and manufacturing services, has appointed Dr Nathalie Huther as its new Chief Commercial Officer (CCO), after the company’s most recent Management Buyout (MBO).